PCOS is known to disrupt the metabolic and hormonal balance, leading to increased oxidative stress biomarkers and impaired antioxidant defences, as evidenced by the significantly lower serum and liver extract levels of CAT, SOD, and GSH-Px in the PCOS group compared to the control group. The gene discussed is CAT; the disease is polycystic ovary syndrome.